Annual CFF
-$45.01 M
-$94.56 M-190.83%
31 December 2022
Summary:
Catalyst Biosciences annual cash flow from financing activities is currently -$45.01 million, with the most recent change of -$94.56 million (-190.83%) on 31 December 2022. During the last 3 years, it has fallen by -$94.56 million (-190.83%).CBIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.48 M
+$2.02 M+57.77%
30 September 2023
Summary:
Catalyst Biosciences quarterly cash flow from financing activities is currently -$1.48 million, with the most recent change of +$2.02 million (+57.77%) on 30 September 2023.CBIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$12.74 M
+$43.55 M+77.37%
30 September 2023
Summary:
Catalyst Biosciences TTM cash flow from financing activities is currently -$12.74 million, with the most recent change of +$43.55 million (+77.37%) on 30 September 2023.CBIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -190.8% | -100.0% | -125.7% |
| 5 y5 years | -10000.0% | -100.0% | -3996.0% |
CBIO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -140.4% | -101.3% | -109.3% |
Catalyst Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.48 M(-57.8%) | -$12.74 M(-77.4%) |
| June 2023 | - | -$3.50 M(-54.9%) | -$56.29 M(+6.6%) |
| Mar 2023 | - | -$7.76 M(<-9900.0%) | -$52.79 M(+17.3%) |
| Dec 2022 | -$45.01 M(-190.8%) | $0.00(-100.0%) | -$45.01 M(0.0%) |
| Sept 2022 | - | -$45.03 M(<-9900.0%) | -$45.01 M(<-9900.0%) |
| June 2022 | - | $0.00(-100.0%) | $114.00 K(+3.6%) |
| Mar 2022 | - | $16.00 K(>+9900.0%) | $110.00 K(-99.8%) |
| Dec 2021 | $49.55 M(-17.9%) | $0.00(-100.0%) | $49.55 M(0.0%) |
| Sept 2021 | - | $98.00 K(-2550.0%) | $49.55 M(+0.4%) |
| June 2021 | - | -$4000.00(-100.0%) | $49.38 M(-36.3%) |
| Mar 2021 | - | $49.46 M(>+9900.0%) | $77.47 M(+28.3%) |
| Dec 2020 | $60.38 M(>+9900.0%) | $0.00(-100.0%) | $60.38 M(0.0%) |
| Sept 2020 | - | -$75.00 K(-100.3%) | $60.38 M(-0.3%) |
| June 2020 | - | $28.09 M(-13.2%) | $60.54 M(+85.8%) |
| Mar 2020 | - | $32.36 M(>+9900.0%) | $32.59 M(+9864.8%) |
| Dec 2019 | $327.00 K(-99.7%) | $0.00(-100.0%) | $327.00 K(-17.8%) |
| Sept 2019 | - | $92.00 K(-28.7%) | $398.00 K(+30.1%) |
| June 2019 | - | $129.00 K(+21.7%) | $306.00 K(+43.0%) |
| Mar 2019 | - | $106.00 K(+49.3%) | $214.00 K(-99.8%) |
| Dec 2018 | $111.33 M(+428.1%) | $71.00 K(>+9900.0%) | $111.33 M(-8.9%) |
| Sept 2018 | - | $0.00(-100.0%) | $122.20 M(+0.2%) |
| June 2018 | - | $37.00 K(-100.0%) | $121.92 M(-11.2%) |
| Mar 2018 | - | $111.22 M(+916.8%) | $137.28 M(+551.2%) |
| Dec 2017 | $21.08 M(+2123.8%) | $10.94 M(-3979.1%) | $21.08 M(+106.2%) |
| Sept 2017 | - | -$282.00 K(-101.8%) | $10.23 M(-8.8%) |
| June 2017 | - | $15.39 M(-409.8%) | $11.22 M(-378.9%) |
| Mar 2017 | - | -$4.97 M(-6088.0%) | -$4.02 M(-524.3%) |
| Dec 2016 | $948.00 K(-89.8%) | $83.00 K(-88.3%) | $948.00 K(-8.1%) |
| Sept 2016 | - | $710.00 K(+358.1%) | $1.03 M(-89.1%) |
| June 2016 | - | $155.00 K(>+9900.0%) | $9.51 M(+3.1%) |
| Mar 2016 | - | $0.00(-100.0%) | $9.22 M(-1.0%) |
| Dec 2015 | $9.31 M(+262.1%) | $167.00 K(-98.2%) | $9.31 M(+7.4%) |
| Sept 2015 | - | $9.19 M(-7058.3%) | $8.67 M(-1272.9%) |
| June 2015 | - | -$132.00 K(-241.9%) | -$739.00 K(-7.9%) |
| Mar 2015 | - | $93.00 K(-119.5%) | -$802.00 K(-131.2%) |
| Dec 2014 | $2.57 M | -$478.00 K(+115.3%) | $2.57 M(-15.1%) |
| Sept 2014 | - | -$222.00 K(+13.8%) | $3.03 M(-2.0%) |
| June 2014 | - | -$195.00 K(-105.6%) | $3.09 M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $3.47 M(<-9900.0%) | $3.12 M(-665.4%) |
| Dec 2013 | -$552.00 K(-11.8%) | -$22.00 K(-86.3%) | -$552.00 K(-23.9%) |
| Sept 2013 | - | -$160.00 K(-2.4%) | -$725.00 K(+112.6%) |
| June 2013 | - | -$164.00 K(-20.4%) | -$341.00 K(+4.9%) |
| Mar 2013 | - | -$206.00 K(+5.6%) | -$325.00 K(-48.1%) |
| Dec 2012 | -$626.00 K(-100.8%) | -$195.00 K(-187.1%) | -$626.00 K(-35.4%) |
| Sept 2012 | - | $224.00 K(-251.4%) | -$969.00 K(-43.5%) |
| June 2012 | - | -$148.00 K(-70.8%) | -$1.71 M(-102.1%) |
| Mar 2012 | - | -$507.00 K(-5.8%) | $81.74 M(-1.3%) |
| Dec 2011 | $82.81 M(+1184.7%) | -$538.00 K(+3.3%) | $82.81 M(-3.0%) |
| Sept 2011 | - | -$521.00 K(-100.6%) | $85.36 M(-2.0%) |
| June 2011 | - | $83.31 M(>+9900.0%) | $87.08 M(+1315.5%) |
| Mar 2011 | - | $567.00 K(-71.7%) | $6.15 M(-4.6%) |
| Dec 2010 | $6.45 M(-86.3%) | $2.00 M(+66.8%) | $6.45 M(-87.6%) |
| Sept 2010 | - | $1.20 M(-49.5%) | $51.90 M(+1.6%) |
| June 2010 | - | $2.38 M(+176.2%) | $51.07 M(+5.6%) |
| Mar 2010 | - | $861.00 K(-98.2%) | $48.35 M(+2.5%) |
| Dec 2009 | $47.18 M(+49.4%) | $47.45 M(>+9900.0%) | $47.18 M(-7065.6%) |
| Sept 2009 | - | $375.00 K(-211.6%) | -$677.30 K(-15.5%) |
| June 2009 | - | -$336.00 K(+6.3%) | -$801.80 K(-1.3%) |
| Mar 2009 | - | -$316.00 K(-21.1%) | -$812.20 K(-102.6%) |
| Dec 2008 | $31.58 M(+140.9%) | -$400.30 K(-259.8%) | $31.58 M(-1.3%) |
| Sept 2008 | - | $250.50 K(-172.3%) | $31.98 M(-25.7%) |
| June 2008 | - | -$346.40 K(-101.1%) | $43.03 M(-5.0%) |
| Mar 2008 | - | $32.08 M(>+9900.0%) | $45.30 M(+245.6%) |
| Dec 2007 | $13.11 M(-67.3%) | $2300.00(-100.0%) | $13.11 M(+0.8%) |
| Sept 2007 | - | $11.30 M(+486.4%) | $13.00 M(+930.2%) |
| June 2007 | - | $1.93 M(-1725.6%) | $1.26 M(-96.9%) |
| Mar 2007 | - | -$118.50 K(+14.8%) | $40.20 M(+0.4%) |
| Dec 2006 | $40.05 M(-2418.8%) | -$103.20 K(-76.7%) | $40.05 M(+0.5%) |
| Sept 2006 | - | -$442.60 K(-101.1%) | $39.87 M(+2.8%) |
| June 2006 | - | $40.87 M(<-9900.0%) | $38.78 M(-2293.6%) |
| Mar 2006 | - | -$268.40 K(-6.2%) | -$1.77 M(+2.4%) |
| Dec 2005 | -$1.73 M(-104.8%) | -$286.20 K(-81.3%) | -$1.73 M(+19.9%) |
| Sept 2005 | - | -$1.53 M(-578.2%) | -$1.44 M(-1649.5%) |
| June 2005 | - | $320.80 K(-240.8%) | $93.00 K(-140.8%) |
| Mar 2005 | - | -$227.80 K | -$227.80 K |
| Dec 2004 | $35.94 M | - | - |
FAQ
- What is Catalyst Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Catalyst Biosciences?
- What is Catalyst Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Catalyst Biosciences?
What is Catalyst Biosciences annual cash flow from financing activities?
The current annual CFF of CBIO is -$45.01 M
What is the all time high annual CFF for Catalyst Biosciences?
Catalyst Biosciences all-time high annual cash flow from financing activities is $111.33 M
What is Catalyst Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of CBIO is -$1.48 M
What is the all time high quarterly CFF for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly cash flow from financing activities is $111.22 M
What is Catalyst Biosciences TTM cash flow from financing activities?
The current TTM CFF of CBIO is -$12.74 M
What is the all time high TTM CFF for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM cash flow from financing activities is $137.28 M